Tumor-infiltrating CD14+CD1c+ DCs have been reported in multiple instances, including ovarian cancer ascites (Segura et al., 2013), breast cancer (Michea et al., 2018), and melanoma (Bakdash et al., 2016; Binnewies et al., 2019). Here, CD1C is linked to breast carcinoma.